TNNI3 p.Arg162Gln

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 17 classification points (ACMG Germline Pathogenicity v2019). PS3PM1PM2_SupportingPM5PP5_Very_Strong

The NM_000363.5(TNNI3):c.485G>A (p.Arg162Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000322 (AC=47) in the gnomAD database across 1,461,004 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000655. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000209175: Published in vitro functional studies using HEK293 cells showed that the R162Q variant results in a 50% reduction of the troponin I and troponin C interaction (Doolan et al., 2005)" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R162P: Pathogenic/Likely_pathogenic (ClinVar VariationId 43390, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R162?: Uncertain_significance (ClinVar VariationId 454407, 1 star); p.R162G: Uncertain_significance (ClinVar VariationId 3071848, 1 star); p.R162= (synonymous): Likely_benign (ClinVar VariationId 3231263, 2 stars); p.R162= (synonymous): Likely_benign (ClinVar VariationId 1060070, 1 star); p.R162W: Uncertain_significance (ClinVar VariationId 161396, 3 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000032 ( 0 hom. )

Consequence

TNNI3
NM_000363.5 missense

Scores

1
9
10

Clinical Significance

Likely pathogenic reviewed by expert panel P:29

Conservation

PhyloP100: 4.05

Publications

20 publications found
Variant links:
Genes affected
TNNI3 (HGNC:11947): (troponin I3, cardiac type) Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020]
TNNI3 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • dilated cardiomyopathy 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • cardiomyopathy, familial restrictive, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy 1FF
    Inheritance: AD Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated restrictive cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000363.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 17 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000209175: Published in vitro functional studies using HEK293 cells showed that the R162Q variant results in a 50% reduction of the troponin I and troponin C interaction (Doolan et al., 2005); SCV000280508: There is also expertimental evidence that suggests this variant dirupts protein-protein interactions.; SCV000059952: "In vitro functional studies using a mammalian two-hybrid system suggests that this variant may impact protein function by affecting the interaction with other binding partners (troponin T and troponin C;" PMID:15698845); SCV000253837: Experimental studies have shown that this missense change affects TNNI3 function (PMID: 15698845).; SCV004819051: "A functional study has shown that this variant disrupts interactions with troponin C and T (PMID: 15698845)."; SCV001358527: "A functional study has shown that this variant disrupts interactions with troponin C and T (PMID: 15698845)."; SCV000996359: A mammalian two-hybrid system has shown that this missense change decreases troponin T and troponin C interaction (Doolan A, et al., 2005), whereas crystal structure modelling suggests that the Arg162Gln affects troponin C stability (Ramachandran G, et al., 2013).
PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 10 pathogenic, 0 benign (OR vs. background: 105.0).
PM2Absent/extremely low in population databases
Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000655 — borderline rare for AD+AR gene (threshold 0.0001) — PM2 supporting.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R162P: Pathogenic/Likely_pathogenic (ClinVar VariationId 43390, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.R162?: Uncertain_significance (ClinVar VariationId 454407, 1 star); p.R162G: Uncertain_significance (ClinVar VariationId 3071848, 1 star); p.R162= (synonymous): Likely_benign (ClinVar VariationId 3231263, 2 stars); p.R162= (synonymous): Likely_benign (ClinVar VariationId 1060070, 1 star); p.R162W: Uncertain_significance (ClinVar VariationId 161396, 3 stars)
PP5Reputable source reports pathogenic
ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (29/29 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000363.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TNNI3 NM_000363.5
MANE Select
HGVSc / HGVSpc.485G>Ap.Arg162Gln
Exon rankExon 7 of 8
missense
Prot: NP_000354.4

Ensembl Transcripts

TNNI3 ENST00000344887.10
TSL:1MANE Select
HGVSc / HGVSpc.485G>Ap.Arg162Gln
Exon rankExon 7 of 8
missense
Prot: ENSP00000341838.5UniProt: P19429
TNNI3 ENST00000665070.1
HGVSc / HGVSpc.518G>Ap.Arg173Gln
Exon rankExon 7 of 8
missense
Prot: ENSP00000499482.1UniProt: A0A590UJN1
TNNI3 ENST00000714238.1
HGVSc / HGVSpc.473G>Ap.Arg158Gln
Exon rankExon 7 of 8
missense
Prot: ENSP00000519518.1UniProt: A0AAQ5BHR0

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.00000658
AC:1
Hom:0
AN:152006
Cov:31
GnomAD2 exomes
AF: 0.0000402
AC:10
AN:249030
GnomAD4 exome
AF: 0.0000322
AC:47
Hom:0
AN:1461004
Cov:32
GnomAD4 genome
Warning
AF: 0.00000658
AC:1
Hom:0
AN:152006
Cov:31
TOPMed (Bravo)
AF: 0.0000113
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000552
AC:5
Hom:0
AN:90516
Local & regional cohorts 3 sources
ChinaMAP Phase 1
AF: 0.0000492
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.00000800
AC:1
Hom:0
AN:122136
Turkish Variome
AF: 0.000647
AC:1
Hom:0
AN:1546
Showing 9 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
BipEx
(Bipolar disorder (including schizoaffective))
0.000106 328420 0.0000347 128844
Epi25
(Epilepsy)
0.0000477 241958 0.0000449 366888
SCHEMA
(Schizophrenia)
0.0000291 3103196 0.0000271 5184284
Showing 3 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
9
-
-
not provided (9)
6
-
-
Hypertrophic cardiomyopathy 7 (6)
4
-
-
Hypertrophic cardiomyopathy (4)
2
-
-
Cardiomyopathy (2)
2
-
-
Cardiovascular phenotype (2)
2
-
-
Hypertrophic cardiomyopathy 7;C1861861:Cardiomyopathy, familial restrictive, 1;C2678474:Dilated cardiomyopathy 2A;C2750091:Dilated cardiomyopathy 1FF (2)
2
-
-
Primary familial hypertrophic cardiomyopathy (2)
1
-
-
Dilated cardiomyopathy 1FF (1)
1
-
-
TNNI3-related disorder (1)

Computational Scores

AlphaGenome AVI
Pathogenic20
AlphaMissense
Benign0.11
BayesDel_addAF
Benign-0.080T
BayesDel_noAF
Benign-0.17
CADD
Benign23
CardioboostCm
Uncertain0.15
DANN
Pathogenic1.0
DEOGEN2
Uncertain0.67D
Eigen
Benign0.083
Eigen_PC
Uncertain0.22
FATHMM_MKL
Benign0.61D
FuncVEP CTI
Benign0.38
GPN-Star LLR
N/A-6.4
GPN-Star score
N/A6.4
LIST_S2
Uncertain0.93D
M_CAP
Uncertain0.16D
MetaRNN
Uncertain0.65D
MetaSVM
Uncertain-0.062T
Mutation Taster
N/A14/86disease causing (ClinVar)
MutationAssessor
Benign0.83L
PhyloP100
Uncertain4.0
popEVE
Benign-3.1
PrimateAI
Uncertain0.55T
PROVEAN
Benign-1.1N
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
REVEL
Uncertain0.36
Sift
Benign0.031D
Sift4G
Benign0.063T
Varity_R
N/A0.33
VESM-3B
Benign-7.1
Showing 31 of 31 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs397516354;
hg19: chr19-55665462;
COSMIC: COSV52573571;
COSMIC: COSV52573571;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.